Healthcare strategy

Since it’s February, the month of love, we can’t help but notice that scaling a healthcare data integrations team feels a lot like dating. And just like dating, the goal isn’t a flashy first impression; it’s a partner who shows up consistently, adapts as you grow, and stays steady when things get complicated. You deserve an interoperability partner who’s in it for the long haul, not just a phase.

Point solutions are built to optimize for a vertical set of use cases. Interoperability partners create the conditions for many. The difference matters more as healthcare organizations look to apply analytics, automation, and AI at scale. Without a strong interoperability foundation, teams spend more time rebuilding plumbing than improving care.

Meet Sasi Mukkamala, Redox’s new CTO. After years building AI-powered products that rely on clean upstream data, Sasi joined Redox to help elevate our platform into the intelligent foundation healthcare needs for AI at scale. Sasi’s debut post shares why Redox’s intelligent platform is uniquely positioned to deliver real operational value through AI.

As Force Therapeutics and Redox mark a decade of partnership, we celebrate the longevity of our collaboration as well as the measurable impact it has had on the healthcare ecosystem. Together, we have reimagined how data, technology, and clinical expertise converge to power a more connected, efficient, and patient-centered model of care.

What if your data could arrive in the right condition from the start? This could include normalization of clinical codes, adding missing context from third party sources, or validating quality/accuracy. In this post, we’ll explore how solving data quality problems “in-flight” (or upstream) doesn’t just save time—it creates a lasting strategic advantage.

When it comes to interoperability, if you feel like a frustrated little kid sitting in the back of the car screaming “are we there yet?”, you’re not alone. In this post, we’ll explore why flexibility is the key to true interoperability, and share how leading organizations are already demanding platforms that adapt to their unique workflows.

The future of interoperability is plural. FHIR and non-FHIR. Direct and delegated. One network and another. The new CMS pledge embraces this plurality, pushing our industry toward faster, more open, and more connected data exchange. In the August installment of “Connections” read our CEO Trip Hofer’s reflections on why plurality is the only path forward.

Today’s provider IT leaders are in triage mode. Capital is tight. Priorities are shifting. And what used to be a greenfield opportunity now comes with a demand for clear value, fast. Based on our work with hundreds of vendor partners across more than 14,000 live integrations, dive into 5 strategies we’ve seen that resonate in today’s complex healthcare market.

Redox now supports TEFCA participation through a direct onramp to CommonWell, making it faster and easier for customers to connect to the evolving national exchange network. In this blog post we’ll explore why TEFCA is gaining momentum and how Redox helps organizations connect without the complexity.

In our June 2025 “Connections” post, Redox CEO Trip Hofer reflects on key takeaways from the June CMS interoperability event in Washington, D.C. Read our take on insights from industry leaders, and learn why the future of healthcare data exchange depends on partnership, openness, and a more modular approach to platform design.

Welcome to the first installment of our new Redox “Connections” thought leadership series. In our May 2025 post, Redox Field CTO Tim Kessler reflects on the evolution of integration, why RPA fills a critical gap, and how healthcare can move forward to achieve the “right way” of sustainable integration.

We’re excited to announce the launch of “Connections,” a new insights series from Redox authored by leaders at the company. Each installment will offer perspectives on timely, relevant topics shaping the future of healthcare and healthcare data interoperability.